chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: FLUX
Symptoms: COVID-19, Influenza
Clinical narrative: This case involves Adult and unknown gender patient who experienced got the flu and covid while receiving vaccine INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient developed a non-serious got the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. On an unknown date the patient developed a non-serious covid (covid-19) (unknown latency) following the administration of INFLUENZA VACCINE. Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable. It was not reported if the patient received a corrective treatment for the events (got the flu, Covid). At time of reporting, the outcome was Unknown for the event got the flu and was Unknown for the event covid.
Sex: U
Vaccine: FLU4
Symptoms: Local reaction, Skin test positive
Clinical narrative: positive skin tests using the Fluzone Quadrivalent vaccine; local reaction; Initial information received on 04-Jan-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves Adult and unknown gender patient who experienced positive skin tests using the fluzone quadrivalent vaccine and local reaction while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious positive skin tests using the fluzone quadrivalent vaccine (skin test positive) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  On an unknown date the patient developed a non-serious local reaction (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QUADRIVALENT) was not applicable.  It was not reported if the patient received a corrective treatment for the events (positive skin tests using the Fluzone Quadrivalent vaccine, local reaction).  At time of reporting, the outcome was Unknown for the event positive skin tests using the fluzone quadrivalent vaccine and was Unknown for the event local reaction.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: This case involves a patient of unknown demographics who experienced flu while receiving vaccine INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE (formulation, strength: unknown) produced by unknown manufacturer lot number not reported in unknown administration site as prophylactic vaccination. On an unknown date the patient developed a non-serious event "flu" (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. It was reported" I stopped getting the flu after I stopped getting the flu vaccine. 15-year period where I got the shot every year after getting into nursing. Then every year I would get the flu sometime that season. Prior to that I was not catching the flu. Makes you wonder." Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable. It was not reported if the patient received a corrective treatment for the event (flu). At time of reporting, the outcome was Unknown for the event flu.
Sex: U
Vaccine: FLUX
Symptoms: Pain, Vaccination site pain
Clinical narrative: This case involves Adult and unknown gender patient who reported that it hurts but it's a fun pain while receiving vaccine INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient developed a non-serious event "it hurts but it's a fun pain" (vaccination site pain) (unknown latency) following the administration of INFLUENZA VACCINE. Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable. It was not reported if the patient received a corrective treatment for the event (it hurts but it's a fun pain). At time of reporting, the outcome was Unknown for the event it hurts but it's a fun pain.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: This case involves an unknown age and unknown gender patient who experienced 2 worst flu season while receiving vaccine INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (unknown formulation and strength)  produced by unknown manufacturer (lot number not reported ) via unknown route in unknown administration site. for immunization. On an unknown date the patient developed a non-serious 2 worst flu season (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. It was reported " I've had 2 flu shots - 2 worst flu season I ever had." Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable. It was not reported if the patient received a corrective treatment for the event (2 worst flu season ). At time of reporting, the outcome was Unknown for the event 2 worst flu season.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: once in five years got the flu; Initial information received on 06-Jan-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.   This case involves Adult and unknown gender patient who experienced once in five years got the flu while receiving vaccine INFLUENZA VACCINE.     The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via intra-arterial route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious once in five years got the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported, "Got ours in Oct. also, always do that most years it works, once in five years got the flu anyway but there's so many strains can't guarantee. Pretty good average, worth it."  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (once in five years got the flu).  At time of reporting, the outcome was Unknown for the event once in five years got the flu.
Sex: U
Vaccine: FLUX
Symptoms: Illness, Malaise
Clinical narrative: This case involves an unknown age and unknown gender patient who reported only time I got sick was 20 years ago when I got a flu shot while receiving vaccine INFLUENZA VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination. On an unknown date the patient developed a non-serious event "only time I got sick was 20 years ago when I got a flu shot" (illness) (unknown latency) following the administration of INFLUENZA VACCINE. Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable. It was not reported if the patient received a corrective treatment for the event (ONLY time I got sick was 20 years ago when I got a flu shot). At time of reporting, the outcome was Unknown for the event only time I got sick was 20 years ago when I got a flu shot.
Sex: U
Vaccine: FLUX
Symptoms: Illness, Malaise
Clinical narrative: got all shots and some made very sick; Initial information was received on 09-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a patient.  This case involves an unknown demographics patient who got all shots and some made very sick while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, dose, route, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination (immunization).   On an unknown date the patient developed a non-serious event "got all shots and some made very sick" (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (got all shots and some made very sick).  At time of reporting, the outcome was Unknown for the event got all shots and some made very sick.
Sex: U
Vaccine: FLUX
Symptoms: Malaise
Clinical narrative: Sick long time; Initial information received on 10-Jan-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp via social media.  This case involves Adult and unknown gender patient who was sick long time while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (strength, formulation, frequency,administration site, route, lot number and expiry date was unknown) for prophylactic vaccination.  On an unknown date the patient developed a non-serious event "sick long time" (malaise) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported"only ever 1 flu shot...sick long time."  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Sick long time).  At time of reporting, the outcome was Unknown for the event sick long time.
Sex: M
Vaccine: DTAPIPVHIB, PNC
Symptoms: Medication error, No adverse event, Syringe issue, Underdose
Clinical narrative: This case involves a 1 years old male patient who experienced when nurse gave injection it dripped down the patient's leg with no reported adverse event while receiving vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] and while treated with PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) [PREVNAR]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included INFLUENZA VACCINE (INFLUENZA VACCINE) for Prophylactic vaccination. On 15-Dec-2021, the patient started taking PREVNAR (PNEUMOCOCCAL VACCINE CONJ 7V (CRM197)) Unknown dosage unknown intramuscular (with an unknown batch number) for Prophylactic vaccination. On 15-Dec-2021, the patient received a  dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5)/HIB (PRP/T) VACCINE lot UJ570AAA via intramuscular route in left leg for  Prophylactic vaccination. On 15-Dec-2021, the patient developed a non-serious event, "when nurse gave injection it dripped down the patient's leg with no reported adverse event" (incorrect dose administered) (same day latency).It was reported, " when nurse gave injection it dripped down the patient's leg. She asks for appropriate follow-up. She is not sure which vaccine, Prevnar or Pentacel, was the one that dripped" Action taken with DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE (PENTACEL) and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) was not applicable. It was not reported if the patient received a corrective treatment for the event (when nurse gave injection it dripped down the patient's leg with no reported adverse event). At time of reporting, the outcome was Unknown for the event when nurse gave injection it dripped down the patient's leg with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 71.0
Sex: F
Vaccine: FLU4
Symptoms: Blood test abnormal
Clinical narrative: dinitrophenyl high levels noted in her blood; Initial information received on 07-Jan-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves a 71 years old female patient who reported dinitrophenyl high levels noted in her blood while receiving vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past medical history, medical treatment(s),concomitant medication, vaccination(s) and family history were not provided.   On 30-Sep-2021, the patient received an unknown dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE  once (strength, formulation, lot number and expiry date was unknown) via intramuscular route in the left arm for immunization.  On an unknown date the patient developed a non-serious event " dinitrophenyl high levels noted in her blood "(blood test abnormal) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  It was reported"calling to find out if FLUZONE HIGH DOSE QUADRIVALENT has dinitrophenyl in the vaccine or in the making of the vaccine. Caller stated she had lab work done and the lab technician advised the patient that she had high levels noted in her blood."   Relevant laboratory test results included: Laboratory test - On an unknown date:  [dinitrophenyl high levels noted in her blood]  Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE HIGH-DOSE QUADRIVALENT) was not applicable.  It was not reported if the patient received a corrective treatment for the event (dinitrophenyl high levels noted in her blood).  At time of reporting, the outcome was Unknown for the event dinitrophenyl high levels noted in her blood.
Age: 25.0
Sex: M
Vaccine: RAB
Symptoms: Expired product administered, No adverse event
Clinical narrative: received an expired dose of imovax today with no reported adverse event; Initial information received on 10-Jan-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 25 years old male patient who had received an expired dose of imovax today with no reported adverse event while receiving vaccine RABIES (HDC) VACCINE [IMOVAX RABIES].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect RABIES (HDC) VACCINE lot T1B813M via unknown route in unknown administration site.  On an unknown date the patient developed a non-serious received an expired dose of imovax today with no reported adverse event (expired product administered) (unknown latency) following the administration of RABIES (HDC) VACCINE.  Action taken with RABIES VACCINE (IMOVAX RABIES) was not applicable.  It was not reported if the patient received a corrective treatment for the event (received an expired dose of imovax today with no reported adverse event).  At time of reporting, the outcome was Unknown for the event received an expired dose of imovax today with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 55.0
Sex: F
Vaccine: RAB
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: delay in receiving their third dose with no reported adverse event; Initial information received on 11-Jan-2022 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves a 55 years old female patient who experienced delay in receiving their third dose with no reported adverse event while receiving vaccine RABIES (HDC) VACCINE [IMOVAX RABIES] delivered by unknown device.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 01-Jan-2022, the patient received a  dose of suspect RABIES (HDC) VACCINE lot number not reported via unknown route in unknown administration site. On 04-Jan-2022 she also received a  dose of the same vaccine  with an unknown batch number via unknown route in unknown administration site. In case batch and expiry date of suspect were requested.  On 08-JAN-2022 the patient developed a non-serious delay in receiving their third dose with no reported adverse event (product use issue) 7 days following the administration of RABIES (HDC) VACCINE. On 11-Jan-2022 she also received a  dose of the same vaccine  with an unknown batch number via unknown route in unknown administration site.  It was reported that "Pharmacist reporting a patient who has received their first two doses of IMOVAX for a post exposure has a delay in receiving their third dose. Caller reporting that the patient is scheduled to come in today for her third dose, although it was due on 08Jan2022. Caller reporting first dose was administered on 01Jan2022 and second dose on 04Jan2022. Caller with question on how to proceed with vaccination schedule after todays dose."  Action taken with RABIES VACCINE (IMOVAX RABIES) was not applicable.  It was not reported if the patient received a corrective treatment for the event (delay in receiving their third dose with no reported adverse event).  At time of reporting, the outcome was Unknown for the event delay in receiving their third dose with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 43.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: inadvertently received a Menactra in her pharmacy on 11-Jan-2022 that had expired on 09-Jan-2022 with no reported adverse event; Initial information received on 11-Jan-2022 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves 43 years old female patient who inadvertently received a Menactra in her pharmacy on 11-Jan-2022 that had expired on 09-jan-2022 with no reported adverse event while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, medical treatment(s), and family history were not provided.  Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) for Prophylactic vaccination.  On 11-Jan-2022, the patient received a 0.5mL dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6828AA; Strength: standard; frequency: once; expiry date: 09-Jan-2022) via intramuscular route in the left arm for prophylactic vaccination.  On 11-Jan-2022 the patient developed a non-serious event "inadvertently received a menactra in her pharmacy on 11-Jan-2022 that had expired on 09-Jan-2022 with no reported adverse event" (expired product administered) (latency: same day).  Action taken with MENINGOCOCCAL VACCINE (MENACTRA) was not applicable.  At time of reporting, the outcome was Unknown for the event inadvertently received a menactra in her pharmacy on 11-jan-2022 that had expired on 09-jan-2022 with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: M
Vaccine: HIBV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: This case involves a 69 years old male patient who was accidentally administered 2 doses of acthib with no reported adverse event while receiving vaccine HIB (PRP/T) VACCINE [ACT-HIB]. The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided. On 04-Dec-2021, the patient received an unknown dose of suspect HIB (PRP/T) VACCINE (strength, formulation, frequency, route, administration site, lot number not and expiry date was unknown) for prophylactic vaccination. On 06-Oct-2021 he again  received a  dose of the same vaccine (strength, formulation, frequency, route, administration site, lot number not and expiry date was unknown). On 11-Jan-2022 he also received again accidentally two 0.5 mL doses of the same vaccine (lot UJ574AAA and expiry date: 20-Sep-2022) via intramuscular route in the left deltoid. On 11-JAN-2022 the patient developed a non-serious  event "accidentally administered 2 doses of acthib with no reported adverse event" (extra dose administered) 3 months 5 days following the administration of HIB (PRP/T) VACCINE. Action taken with HAEMOPHILUS TYPE B (HIB) VACCINE (ACT-HIB) was not applicable. It was not reported if the patient received a corrective treatment for the event (accidentally administered 2 doses of ACTHIB with no reported adverse event). At time of reporting, the outcome was Unknown for the event accidentally administered 2 doses of acthib with no reported adverse event. Reporter causality: related.
Sex: U
Vaccine: DF
Symptoms: No adverse event, Product storage error
Clinical narrative: temperature excursion (>0° to <2°C for =72 hours), with no reported adverse event; Initial information received on 11-Jan-2022 regarding an unsolicited valid non-serious case was received from the health professional.  This case involves an unknown age and unknown gender patient, who had temperature excursion (>0° to <2°c for =72 hours), with no reported adverse event while receiving vaccine TETRAVALENT (CHIMERIC) DENGUE VACCINE [DENGVAXIA].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect TETRAVALENT (CHIMERIC) DENGUE VACCINE (strength, formulation, dosage regimen, lot number not reported) via unknown route in unknown administration site for prophylactic vaccination. Information on batch number was requested.  On an unknown date, the patient developed a non-serious event 'temperature excursion (>0° to <2°c for =72 hours), with no reported adverse event' (product temperature excursion issue) (unknown latency) following the administration of TETRAVALENT (CHIMERIC) DENGUE VACCINE.  It is reported "This is reported as potential AE because of temperature excursion."  Action taken with DENGUE VACCINE (DENGVAXIA) was not applicable.  At time of reporting, the outcome was Unknown for the event temperature excursion (>0° to <2°c for =72 hours), with no reported adverse event.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Influenza like illness, Insomnia, Pain, Pain in extremity
Clinical narrative: High Fever 103.8 for two days, aches and pains flu like symptoms.  Then A week later I am now experiencing tingling, pain and numbness in my hands and feet. My hand go numb while I am sleeping. each day this continues to get more intense.  I am also experiencing insomnia
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pyrexia
Clinical narrative: High Fever 103.8 for two days, aches and pains flu like symptoms.  Then A week later I am now experiencing tingling, pain and numbness in my hands and feet. My hand go numb while I am sleeping. each day this continues to get more intense.  I am also experiencing insomnia
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Endotracheal intubation, Hypoxia, Mental status changes, Pyrexia
Clinical narrative: Covid19 breakthrough.  Pt vaccinated on 03/12/2021.  72 y/o PMH CAD s/p CABGx3, HF, HTN, HLD, DM admitted from home via EMS for c/o AMS, Respiratory distress and fevers.  EMS found pt hypoxic with O2 sat's in the 30's, bagged on route to ER and Intubated upon arrival.  T-105.  Pt started on IV ABX/Steroids and Remdesivir.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory distress, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  Pt vaccinated on 03/12/2021.  72 y/o PMH CAD s/p CABGx3, HF, HTN, HLD, DM admitted from home via EMS for c/o AMS, Respiratory distress and fevers.  EMS found pt hypoxic with O2 sat's in the 30's, bagged on route to ER and Intubated upon arrival.  T-105.  Pt started on IV ABX/Steroids and Remdesivir.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling face
Clinical narrative: I got my booster and I currently have a rash all over my chest and my face is swollen and today looks the same as yesterday except I'm getting little white bumps on my face now.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: The rash that originally started with the first shot back in April (April 20, 2021) continues to plaque me.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Back pain, COVID-19, Chest X-ray normal, SARS-CoV-2 test positive
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 08/03/2021.  73y/o PMH of DM, HTN, BPH, HLD, Parkinson's admitted to ED 1/4/22 with c/o generalized weakness, mild back pain and urinary incontinence x1 week as to weak to get out of bed.  CXR-no acute, afebrile, room air sat 99%.  Pt being considered for rehab placement so COVID PCR ordered and came back + on 1/7/2022.  Treated with IV ABX.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urinary incontinence, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 08/03/2021.  73y/o PMH of DM, HTN, BPH, HLD, Parkinson's admitted to ED 1/4/22 with c/o generalized weakness, mild back pain and urinary incontinence x1 week as to weak to get out of bed.  CXR-no acute, afebrile, room air sat 99%.  Pt being considered for rehab placement so COVID PCR ordered and came back + on 1/7/2022.  Treated with IV ABX.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Appendicectomy, Appendicitis
Clinical narrative: I woke up with severe stomach pain less than 24 hours after vaccination, went to hospital where they diagnosed me with appendicitis, within 8 hours I was in surgery to remove my appendix.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ear, nose and throat examination, Magnetic resonance imaging, Tinnitus
Clinical narrative: symptoms starting to show around May and I noticed more in the summer, I finally had to see a Dr. about the ringing in my left ear which she said I have tinnitus. I have never had ringing in my ear till after the vaccine and now I am stuck with ringing in my ear.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood follicle stimulating hormone, Blood iron, Blood prolactin, Blood thyroid stimulating hormone, Full blood count
Clinical narrative: I have been experiencing irregular bleeding since after my first shot in April. It became regular in July and I took the second shot. From July till now, I have experienced irregular bleeding. Currently, I have been bleeding for over a month which is since my last clinic appointment in November 2021. I did an iron test in November and bought some iron gummies, I also changed my meal plan based on doctor's advice to boost my blood level. I'm too scared and worried to do any other scan because the bills may be outrageous and the bleeding may become worse.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haemorrhage, Serum ferritin, Transferrin
Clinical narrative: I have been experiencing irregular bleeding since after my first shot in April. It became regular in July and I took the second shot. From July till now, I have experienced irregular bleeding. Currently, I have been bleeding for over a month which is since my last clinic appointment in November 2021. I did an iron test in November and bought some iron gummies, I also changed my meal plan based on doctor's advice to boost my blood level. I'm too scared and worried to do any other scan because the bills may be outrageous and the bleeding may become worse.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was beyond use date
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose normal, Disorientation, Loss of consciousness, Musculoskeletal stiffness
Clinical narrative: Patient passed out about 3-5 min after getting shot. He regained consciousness within a minute or sooner. He was disoriented. His arms and body stiffened when he was out, but I dont think it was a seizure. We called emergency services.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Child maltreatment syndrome
Clinical narrative: Pt has high risk co-morbidities/hx of reaction to first vax seen by Doctors -ok to vax  became shakey, monitor 40 mins, no shakiness when left
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea
Clinical narrative: Minstrel cycle stopped after getting Pfizer covid vaccine covid protection
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Hypoaesthesia, Pain of skin, Paraesthesia, Skin disorder
Clinical narrative: I was vaccinated in January 2021and I received both Pfizer shots. But a month later I started getting these little painful raised sore spots on my scalp. After about a month they opened up and turned into rings after two months it had left a hole. Also had very sharp stabbing pains in abdomen and skin wet very numb and tingly. Got vaccinated again in June 2021, The same thing happened again of course on the scalp, raised sore spots that repeated what I explained above. They both took three months or more to heal yeah leaving holes where they were. Got the booster shot and the same thing happened again only a little more intense. As I sit here writing an hour I have lesions on my scalp that are painful and have opened up and will turn into holes. Eventually I'm thinking they will scar over completely. I believe it's the vaccine that has done this. As explained above the sharp pains in my abdomen. I've never experienced any of these issues before until I got the vaccines. Also I am starting to get tingly fingers like I'm losing feeling in my hands and I get a deep sharp ache in my forearms. I don't know if this is linked to the shots, but it did start after the second time I was vaccinated and after the booster shot. As for the scalp lesions they happened from the first vaccine doses, the second vaccine doses and the booster shot. I don't know if my immune system got over reactive or overactive. Pardon my non-medical term use of words lol I'm not school with medical terms. I am quite worried that this is going to happen to leave holes in my scalp. I hope this helps. I was wondering if this is happened to anybody else? I was wondering if anyone else had issues with scalp lesions?
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: My son has been dealing with unexplained hives that have lasted for months. He gets them every night. He has been on steroids but it is not helping. Finally, the doctors said that most likely due to the covid vaccine. Covid vaccine. Second dose
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present
Clinical narrative: Received Pfizer booster mid-afternoon Tuesday 1/11/22; that evening, observed slightly bloody urine. Seems to be cleared up now, less than 48 hours later
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Lymphadenopathy, Pain
Clinical narrative: After receiving two Pfizer vaccine for COVID-19 and a Moderna booster, I experienced several side effects. I had fever, moderate chills, body aches, joint pains in my hands and swollen lymph nodes in my armpit. I received the vaccine on Monday and just noticed the swelling today (Thursday.) I went from a restless night the day that I received the vaccine to fatigue the next day.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Restlessness
Clinical narrative: After receiving two Pfizer vaccine for COVID-19 and a Moderna booster, I experienced several side effects. I had fever, moderate chills, body aches, joint pains in my hands and swollen lymph nodes in my armpit. I received the vaccine on Monday and just noticed the swelling today (Thursday.) I went from a restless night the day that I received the vaccine to fatigue the next day.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dysphagia, Oropharyngeal pain, Swelling face, Swollen tongue
Clinical narrative: I had a booster shot at pharmacy on 12jan2022. Within 12 minutes I had intestinal upset. With 12 hours I had tounge swelling, minor facial swelling, pain on the right side of my throat, difficulty swallowing, along with the known common symptoms listed on the CDC website. I contacted my doctor's office on 13jan2022. I was not seen though I did request to be seen. The nurse on the phone told me to take an OTC allergy medicine and gave some short dietary suggestions (that I will follow once I can swallow solids). I did have unusual symptoms following the vaccine in May 2020. With the first vaccine: I had a "spacy" feeling that lasted approximately 2 hours. With the 2nd vaccine I had menstrual cycle (bleeding) that continued for approximately a month instead of the common 3-5 days.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Raynaud's phenomenon
Clinical narrative: My 28 year old daughter developed Idopathic Reynauld's Syndrome following her booster shot of Pfizer mRNA Covid Vaccine. She had no issues with her hands or feet prior to receiving the booster. Currently her physicians are running lab tests but the results won't be available for several days. Will send a follow up report once I have details. Labs are pending-will complete with follow up report.
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Rash on my arms/groin/chest After my second Pfizer Covid-19 vax, I noticed this slightly red rash developed on my arms/groin and some on my chest. not very itchy, but noted that it fills with clear fluid if scratched.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: for weeks, I was at home and occasionally went out to a store but usually with someone. mostly did curbside pickup. in the week prior to 1/9/22, I was taking extra precautions like wear the mask every time and sanitize my hands regularly. on 1/9/22, I received my 2nd dose of Pfizer vaccine. I did not have any side effects whatsoever accept about 48 hrs later I developed COVID-19 symptoms. around 6 hrs prior to the symptoms, I had an rtPCR COVID test done. the results of this test were positive. there is too much coincidence here and I think the vaccination had a lot to do with me getting the disease. It may not be directly from the contents of the vaccine but something there caused it. I thought through where else it could come from but can't figure it out. Others that went with me at stores did not develop COVID-19 symptoms.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, Asthenia, COVID-19, Chest X-ray abnormal
Clinical narrative: Covid19 breakthrough.  1st vaccinated on 07/26/2021.  66 y/o PMH DM, HLD, HTN, Bilat pulm emboli, Wegner's dz, AKF, stents presented to ED with c/o Covid + x2 days with symptoms of increasing SOB, weakness, fever, chills, N/V/D, Loss of sense of taste and smell, cough, sore throat, body aches and prod cough with colored sputum.  EMS reported room air sats of 69%.  CXR- focal PNA. O2 on 6L NC. T-100.4.  Treated with IV ABX/Steroids and Remdesivir.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Diarrhoea, Dyspnoea, Nausea, Oropharyngeal pain
Clinical narrative: Covid19 breakthrough.  1st vaccinated on 07/26/2021.  66 y/o PMH DM, HLD, HTN, Bilat pulm emboli, Wegner's dz, AKF, stents presented to ED with c/o Covid + x2 days with symptoms of increasing SOB, weakness, fever, chills, N/V/D, Loss of sense of taste and smell, cough, sore throat, body aches and prod cough with colored sputum.  EMS reported room air sats of 69%.  CXR- focal PNA. O2 on 6L NC. T-100.4.  Treated with IV ABX/Steroids and Remdesivir.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pneumonia, Productive cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Covid19 breakthrough.  1st vaccinated on 07/26/2021.  66 y/o PMH DM, HLD, HTN, Bilat pulm emboli, Wegner's dz, AKF, stents presented to ED with c/o Covid + x2 days with symptoms of increasing SOB, weakness, fever, chills, N/V/D, Loss of sense of taste and smell, cough, sore throat, body aches and prod cough with colored sputum.  EMS reported room air sats of 69%.  CXR- focal PNA. O2 on 6L NC. T-100.4.  Treated with IV ABX/Steroids and Remdesivir.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sputum discoloured, Vaccine breakthrough infection, Vomiting
Clinical narrative: Covid19 breakthrough.  1st vaccinated on 07/26/2021.  66 y/o PMH DM, HLD, HTN, Bilat pulm emboli, Wegner's dz, AKF, stents presented to ED with c/o Covid + x2 days with symptoms of increasing SOB, weakness, fever, chills, N/V/D, Loss of sense of taste and smell, cough, sore throat, body aches and prod cough with colored sputum.  EMS reported room air sats of 69%.  CXR- focal PNA. O2 on 6L NC. T-100.4.  Treated with IV ABX/Steroids and Remdesivir.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was beyond use date
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Injection site pain, Injection site swelling, Joint range of motion decreased, Lymph node pain
Clinical narrative: low fever of 99 (normal body temp is 97.3).  localized injection site pain and swelling. severe swelling in lymph nodes under/near left underarm causing pain. range of motion significantly limited.  feels like severe and deep bruising.  cannot take pain meds other than Tylenol...and Tylenol had no impact.  iced the area twice a day.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia
Clinical narrative: low fever of 99 (normal body temp is 97.3).  localized injection site pain and swelling. severe swelling in lymph nodes under/near left underarm causing pain. range of motion significantly limited.  feels like severe and deep bruising.  cannot take pain meds other than Tylenol...and Tylenol had no impact.  iced the area twice a day.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer 10/11/21 and 11/1/2021. Positive on 1/17/22
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Pfizer 2/26/21 and 10/14/21. Positive on 1/17/22
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia
Clinical narrative: Covid Booster received on 10/29/2021 and dx with pneumonia on 11/01/2021--were told to submit in case this was a reaction to the booster
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dyspepsia, Rash, Urticaria
Clinical narrative: I started having rashes/hives 12 days after the Moderna booster. I did not get that with the first two  Moderna vaccines. I also have been been having heart burn. I went to urgent care.  They said said it could be the booster,  but to wait it out. He said I could be allergic to something also. I have not changed anything recently so that does not make since. I am going on my 3rd week now and it has not gone away. I have never had sensitivities/rashes or hives before. I am also a healthy person.  This does not seem right. I really hope this goes away. It?s been really uncomfortable and embarrassing.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest pain, Chills, Electrocardiogram, Fatigue
Clinical narrative: Ever since I had the Moderna booster I have been randomly experiencing occasional chest pain, chills and body aches, lower jaw(tooth) pain, fatigue and irritability.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Irritability, Pain, Pain in jaw
Clinical narrative: Ever since I had the Moderna booster I have been randomly experiencing occasional chest pain, chills and body aches, lower jaw(tooth) pain, fatigue and irritability.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Constant ringing in the right ear.  It has gotten progressively worse with time.   I have been trying over the counter medicine but am now going to a Doctor to treat it.
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood glucose increased, COVID-19, Chest X-ray normal, Chest discomfort
Clinical narrative: Extreme fatigue tiredness, shortness of breath and tightness in the chest
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head normal, Confusional state, Dyspnoea, Fatigue, Gait disturbance
Clinical narrative: Extreme fatigue tiredness, shortness of breath and tightness in the chest
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Gait inability, Haemoglobin normal, International normalised ratio increased, Laboratory test, SARS-CoV-2 test positive
Clinical narrative: Extreme fatigue tiredness, shortness of breath and tightness in the chest
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Hypoaesthesia, Pain in extremity, Paraesthesia
Clinical narrative: Patient reports since receiving second dose COVID vaccine she has experienced continued left arm / shoulder pain, numbness and tingling. Reports some decreased strength. No acute distress.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Areflexia, Asthenia, Guillain-Barre syndrome, Immunoglobulin therapy, Intensive care
Clinical narrative: Patient began with weakness shortly after the vaccine, and then seen in the ER on 1/10 and then by his primary doctor on 1/11 with worsening weakness.  He was then seen by me in the ER at Hospital on 1/15/2022 with diffuse sensorimotor loss, and areflexia.  Presumably Guillain Barre, and transfered to Medical Center ICU for IVIG and neurology consult.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sensorimotor disorder
Clinical narrative: Patient began with weakness shortly after the vaccine, and then seen in the ER on 1/10 and then by his primary doctor on 1/11 with worsening weakness.  He was then seen by me in the ER at Hospital on 1/15/2022 with diffuse sensorimotor loss, and areflexia.  Presumably Guillain Barre, and transfered to Medical Center ICU for IVIG and neurology consult.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Ataxia, Bell's palsy, Dysarthria, Electromyogram
Clinical narrative: Patient began with weakness shortly after the vaccine, and then seen in the ER on 1/10 and then by his primary doctor on 1/11 with worsening weakness.  He was then seen by me in the ER at Hospital on 1/15/2022 with diffuse sensorimotor loss, and areflexia.  Presumably Guillain Barre, and transfered to Medical Center ICU for IVIG and neurology consult.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Guillain-Barre syndrome, Haemophilus test positive, Hypoventilation, Immunoglobulin therapy
Clinical narrative: Patient began with weakness shortly after the vaccine, and then seen in the ER on 1/10 and then by his primary doctor on 1/11 with worsening weakness.  He was then seen by me in the ER at Hospital on 1/15/2022 with diffuse sensorimotor loss, and areflexia.  Presumably Guillain Barre, and transfered to Medical Center ICU for IVIG and neurology consult.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging, Nerve conduction studies, Sputum culture positive, Streptococcus test positive
Clinical narrative: Patient began with weakness shortly after the vaccine, and then seen in the ER on 1/10 and then by his primary doctor on 1/11 with worsening weakness.  He was then seen by me in the ER at Hospital on 1/15/2022 with diffuse sensorimotor loss, and areflexia.  Presumably Guillain Barre, and transfered to Medical Center ICU for IVIG and neurology consult.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tracheal aspirate culture
Clinical narrative: Patient began with weakness shortly after the vaccine, and then seen in the ER on 1/10 and then by his primary doctor on 1/11 with worsening weakness.  He was then seen by me in the ER at Hospital on 1/15/2022 with diffuse sensorimotor loss, and areflexia.  Presumably Guillain Barre, and transfered to Medical Center ICU for IVIG and neurology consult.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Lymphadenopathy, Rash
Clinical narrative: Swollen lymph gland under arm, rash on upper body redness and swelling at injection site rash lasted one day swollen lymph gland and soreness at injection site site there after 4 days
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient tested positive on 1/16/22
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives over entire body
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, COVID-19, Fall, Gait disturbance, Injury
Clinical narrative: Pt arrives after having a fall last ngiht. pt is in long term facility after having a car accident when he was 4 years old. Pt is always somewhat unsteady to gait. Pt fell getting into bed last night, he was found half on and half off the bed. pt was noted to be more unsteady this morning by staff. pt has a brain shunt. pt is Alert and oriented at his baseline. Pt does not complain of headache but has persistently complained of back pain. Pt has no rib pains to palpation. Pt has midline back pain thoracic and lumbar. Pt is on Plavix and aspirin. pt does not seem to have had loss of consciousness. Pt is here with group home caretaker.  Associated Symptoms: back pain, fall, injury